Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01621711 · ClinicalTrials.gov registry record · NA

Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care

A NA study of Substance Abuse and Alcohol Abuse, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
504
Enrollment target
1
Study location

NCT01621711: Active NA study of Substance Abuse and Alcohol Abuse, sponsored by Kaiser Permanente.

NCT01621711 is a NA study of Substance Abuse and Alcohol Abuse that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 504 participants, below the 5,251-participant average among 58 other Substance Abuse trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01621711, a NA study of Substance Abuse and Alcohol Abuse, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
504 participants
Enrollment target
1
Study location

Study Summary

This component of a larger Center of Research Excellence Grant improves treatment for drug abuse by developing effective linkages between specialty drug treatment and primary health care.

Interventions

  • BEHAVIORAL Linkage patient activation intervention

Study Locations (1)

California

  • Kaiser Permanente, Chemical Dependency Recovery Program - San Francisco

Trial Details

FieldValue
Enrollment Target 504 participants
Start Date 2011-03
Est. Completion 2025-12-31
Phase NA
Kaiser Permanente

294 total trials

What the registry record for NCT01621711 still lists

NCT01621711 is an interventional study that assigns participants to a tested intervention. The registered 504 participants enrollment target is mid-sized for trials with a published cap, below the 5,251-participant average among 58 other Substance Abuse trials with a reported enrollment target (90% lower).

The record links to 4 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Linkage patient activation intervention is the first listed.

NCT01621711 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01621711 about?

NCT01621711 is a clinical study titled "Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care". This component of a larger Center of Research Excellence Grant improves treatment for drug abuse by developing effective linkages between specialty drug treatment and primary health care.

What is the current status of trial NCT01621711?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 504 participants. The study started on 2011-03. Estimated completion is 2025-12-31.

What conditions does trial NCT01621711 study?

This clinical trial studies the following conditions: Substance Abuse, Alcohol Abuse, Substance Dependence, Substance Addiction.

What interventions are being tested in trial NCT01621711?

The interventions under investigation include: Linkage patient activation intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01621711?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01621711 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01621711's enrollment target sits among peer trials

504 13th of 58 higher than 46 of 58 other Substance Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05846282 · 504 participants · NA

    Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience

  • NCT06072131 · 504 participants · Phase 3

    To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

  • NCT06736522 · 504 participants · NA

    Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program

  • NCT06822257 · 504 participants · NA

    Drinking in Young Adult Duos (DYAD) Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01621711, the US trial registry maintained by the National Library of Medicine. NCT01621711 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.